Skip to main content
Caplight Logo









Biotecland

Biotecland

Private
GoiâniaFrontier & Industrial Techhttps://www.biotecland.com/

Last Round

Accelerator

Dec 3, 2024

Total Funding Raised

$270,000

Company Overview

Biotecland is an agtech company that specializes in the development and application of microalgae-based bio-inputs to improve soil quality, increase crop productivity, and promote sustainable agricultural practices.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Sustainable Materials, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware + Subscription, Usage-Based SaaS

AI Layer

Non-AI

Keywords

agritechbioinputsmicroalgae productionon-farm productionbiostimulantsustainable agriculturephotobioreactorsregenerative agriculturebiofertilizerbiologicalssoil healthinoculantsprecision agriculturebiotech equipmentcrop productivity

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biotecland Comparables

Compare Biotecland with similar companies based on industry and business-model similarity.

Biotecland comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tacita Agro
84%
Inocular Soluções Biotecnológicas
82%
BioUs
81%

Biotecland Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorDec 3, 2024
GrantMay 1, 2024
Corporate FundingSep 1, 2022

Key People

Founding team and executive leadership

Dágon Ribeiro

CEO

Executive Team

Biotecland Investors

Notable investors and investment history

Biotecland investors
InvestorRounds
National Bank for Economic and Social DevelopmentAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 3, 2024

    National Bank for Economic and Social Development participated in the round.

  • Oct 30, 2024

    Monthly visitors doubled, reaching 2.4K.

Biotecland Filings

Explore SEC and related filing metadata, where available.

Biotecland filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Biotecland's valuation, stock price, and market status.

Is Biotecland a public or private company?

Biotecland is a private company.

What is the current stock price of Biotecland?

Biotecland is a private company with no public stock price. Caplight tracks Biotecland's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Biotecland worth (valuation)?

Valuation information for Biotecland is not publicly available.

Can I buy Biotecland stock?

Biotecland shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Biotecland's last funding round?

Biotecland's most recent funding round was Accelerator on December 3, 2024.

Who are the main investors in Biotecland?

Key investors in Biotecland include National Bank for Economic and Social Development.

Will Biotecland IPO soon?

No public IPO plans have been announced for Biotecland.

How can I track Biotecland secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biotecland's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGoiânia
Employee Range4
Year Founded2020
Last FundingDec 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?